跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37 条关于
“IMIDs”
全部
37
临床试验
22
药物
2
机构
0
资讯
13
去年
Novel Combination Therapy Trial Launches for Inflammatory Diseases with HudsonAlpha's Genomic Support
去年
Genetic Study Reveals One-Way Link Between Cardiovascular Disease and Psoriasis Risk
9个月前
CRBN Gene Mutations Show Variable Impact on Myeloma Drug Response, Enabling Precision Treatment Selection
去年
Adalimumab Biosimilar SB5 Shows Similar Persistence in New and Switched Patients with Inflammatory Diseases
4个月前
UCB Acquires IMIDomics' Patient Insight Business to Advance Precision Medicine in Immune-Mediated Inflammatory Diseases
去年
ADAR1 Gene Identified as Key Driver of Lenalidomide Resistance in Multiple Myeloma
去年
Sonrotoclax Plus Dexamethasone Shows Promise in Relapsed/Refractory Multiple Myeloma
上个月
The Second Act of Thalidomide: From Teratogen to the Foundation of Targeted Protein Degradation
9个月前
First-in-Class MMSET Inhibitor Gintemetostat Shows Clinical Activity in Heavily Pretreated Multiple Myeloma
6年前
MRD Negativity as a Surrogate Endpoint for PFS in Newly Diagnosed Multiple Myeloma
第 1 页,共 2 页
上一页
下一页